FTC sues major pharmacy reward supervisors in excess of insulin selling prices The agency introduced action towards Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the listing cost of lifetime-preserving insulin drugs. The deal must be done by Sept. thirty or purchasers can https://aya-healthcare-address27261.shotblogs.com/5-easy-facts-about-healthcare-news-described-44651459